Adopting these policies would validate socialized medicine schemes like price controls and rationing.
SCOTUS Says “No” to Expediting Review of Obamacare Lawsuit
On Tuesday, January 21, SCOTUS issued an Orders List for pending cases.
Green New Deal and the Environmental Damage it Would Cause
Everyone has heard about the GND outrageous costs, estimated to be somewhere between $52 to $93 trillion over 10 years.
Sen. Elizabeth Warren Offers More Dangerous Healthcare Ideas
Essentially it is Speaker Nancy Pelosi’s (D-Calif.) socialistic drug discount plan, H.R. 3, on steroids.
U.S. Fifth Circuit Court of Appeals Agrees: Obamacare Individual Mandate is Unconstitutional
No one who purchases health insurance in an Obamacare exchange will lose their health insurance.
USMCA Steps Back on Intellectual Property Protection
The administration and Congress should support IP protection in trade deals that respect and adhere as closely as possible to U.S. laws.
Let’s Not Import Bad Ideas Like International Price Indexing
How long do you think television companies would stay in business if the government told them to charge $200 for a TV even though the TV costs $250 to manufacture? Not very long, but that is exactly what the socialists in Congress want to do with prescription drugs. They want to use “international price indexing” […]
CBO Releases the “Savings” Expected from Speaker Pelosi’s Drug Pricing Bill
H.R. 3 exerts so much government authority over the pharmaceutical industry.
Two Trump Administration Proposed Rules Promise Less Government Waste and More Transpareny in Healthcare
The Trump administration recently released two proposed rules. One is designed to bring more fiscal integrity to Medicaid, a federal and state program with shared dollars that are used to provide healthcare for low-income people. The other rule is designed to provide more accessible information for patients about medical costs. The Centers for Medicare and […]
When Will Politicians Learn, Price Controls Do Not Work?
A new bill would create an independent federal agency that would determine and regulate the cost of prescription medications.